253 related articles for article (PubMed ID: 26071930)
1. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy - A quality of life and cost effectiveness analysis.
Gibbons JP; Nugent E; O'Donohoe N; Maher B; Egan B; Feeley M; Tierney S
Surgeon; 2016 Oct; 14(5):260-4. PubMed ID: 26071930
[TBL] [Abstract][Full Text] [Related]
2. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
[TBL] [Abstract][Full Text] [Related]
3. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Impact of Endoscopic Thoracic Sympathectomy for Primary Palmar Hyperhidrosis.
Horslen LC; Wilshire CL; Louie BE; Vallières E
Ann Thorac Surg; 2018 Oct; 106(4):1008-1012. PubMed ID: 29885977
[TBL] [Abstract][Full Text] [Related]
6. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T; Konrad H; Karte K; Wollina U
Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
[TBL] [Abstract][Full Text] [Related]
7. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
[TBL] [Abstract][Full Text] [Related]
8. Treatment of palmar hyperhidrosis: T(4) level compared with T(3) and T(2).
Chang YT; Li HP; Lee JY; Lin PJ; Lin CC; Kao EL; Chou SH; Huang MF
Ann Surg; 2007 Aug; 246(2):330-6. PubMed ID: 17667514
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
Maillard H; Briand N; Bara C; Celerier P
Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of botulinum toxin versus thoracic sympathectomy for palmar hyperhidrosis: data from a real-world scenario.
Isla-Tejera B; Ruano J; Alvarez MA; Brieva T; Cárdenas M; Baamonde C; Salvatierra A; Del Prado-Llergo JR; Moreno-Giménez JC
Dermatol Ther (Heidelb); 2013 Jun; 3(1):63-72. PubMed ID: 23888256
[TBL] [Abstract][Full Text] [Related]
13. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
15. [Management of axillary hyperhidrosis].
Pomarède N
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478
[TBL] [Abstract][Full Text] [Related]
16. One-year follow-up period after transumbilical thoracic sympathectomy for hyperhidrosis: outcomes and consequences.
Zhu LH; Du Q; Chen L; Yang S; Tu Y; Chen S; Chen W
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):25-8. PubMed ID: 24176274
[TBL] [Abstract][Full Text] [Related]
17. Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases.
Lin TS; Kuo SJ; Chou MC
Neurosurgery; 2002 Nov; 51(5 Suppl):S84-7. PubMed ID: 12234434
[TBL] [Abstract][Full Text] [Related]
18. Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients.
Marcella S; Goodman G; Cumming S; Foley P; Morgan V
Australas J Dermatol; 2011 May; 52(2):123-6. PubMed ID: 21605096
[TBL] [Abstract][Full Text] [Related]
19. Predictors of outcome following endoscopic thoracic sympathectomy.
Bell D; Jedynak J; Bell R
ANZ J Surg; 2014; 84(1-2):68-72. PubMed ID: 23432865
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
Nelson L; Bachoo P; Holmes J
Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
